-
Something wrong with this record ?
Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma
P. Busek, E. Balaziova, I. Matrasova, M. Hilser, R. Tomas, M. Syrucek, Z. Zemanova, E. Krepela, J. Belacek, A. Sedo,
Language English Country United States
Document type Comparative Study, Journal Article
Grant support
NT12237
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Medline Complete (EBSCOhost)
from 2005-01-01 to 2016-12-31
ROAD: Directory of Open Access Scholarly Resources
from 1987
- MeSH
- Apoptosis MeSH
- Stromal Cells metabolism pathology MeSH
- Adult MeSH
- Fibroblasts metabolism pathology MeSH
- Glioblastoma genetics metabolism pathology MeSH
- Immunoenzyme Techniques MeSH
- Real-Time Polymerase Chain Reaction MeSH
- Middle Aged MeSH
- Humans MeSH
- Membrane Proteins genetics metabolism MeSH
- RNA, Messenger genetics MeSH
- Mesoderm metabolism pathology MeSH
- Survival Rate MeSH
- Mice, Inbred NOD MeSH
- Mice MeSH
- Biomarkers, Tumor metabolism MeSH
- Tumor Cells, Cultured MeSH
- Follow-Up Studies MeSH
- Reverse Transcriptase Polymerase Chain Reaction MeSH
- Prognosis MeSH
- Cell Proliferation MeSH
- Aged MeSH
- Serine Endopeptidases genetics metabolism MeSH
- Neoplasm Staging MeSH
- Case-Control Studies MeSH
- Cell Line, Transformed metabolism pathology MeSH
- Blotting, Western MeSH
- Xenograft Model Antitumor Assays MeSH
- Gelatinases genetics metabolism MeSH
- Animals MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Mice MeSH
- Aged MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
Glioblastomas are deadly neoplasms resistant to current treatment modalities. Fibroblast activation protein (FAP) is a protease which is not expressed in most of the normal adult tissues but is characteristically present in the stroma of extracranial malignancies. FAP is considered a potential therapeutic target and is associated with a worse patient outcome in some cancers. The FAP localization in the glioma microenvironment and its relation to patient survival are unknown. By analyzing 56 gliomas and 15 non-tumorous brain samples, we demonstrate increased FAP expression in a subgroup of high-grade gliomas, in particular on the protein level. FAP expression was most elevated in the mesenchymal subtype of glioblastoma. It was neither associated with glioblastoma patient survival in our patient cohort nor in publicly available datasets. FAP was expressed in both transformed and stromal cells; the latter were frequently localized around dysplastic blood vessels and commonly expressed mesenchymal markers. In a mouse xenotransplantation model, FAP was expressed in glioma cells in a subgroup of tumors that typically did not express the astrocytic marker GFAP. Endogenous FAP was frequently upregulated and part of the FAP(+) host cells coexpressed the CXCR4 chemokine receptor. In summary, FAP is expressed by several constituents of the glioblastoma microenvironment, including stromal non-malignant mesenchymal cells recruited to and/or activated in response to glioma growth. The limited expression of FAP in healthy tissues together with its presence in both transformed and stromal cells suggests that FAP may be a candidate target for specific delivery of therapeutic agents in glioblastoma.
Department of Neurosurgery Na Homolce Hospital Roentgenova 2 150 30 Prague 5 Czech Republic
Department of Pathology Na Homolce Hospital Roentgenova 2 150 30 Prague 5 Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013600
- 003
- CZ-PrNML
- 005
- 20191015075944.0
- 007
- ta
- 008
- 170413s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s13277-016-5274-9 $2 doi
- 035 __
- $a (PubMed)27492457
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Bušek, Petr $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic. busekpetr@seznam.cz. $7 xx0094315
- 245 10
- $a Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma / $c P. Busek, E. Balaziova, I. Matrasova, M. Hilser, R. Tomas, M. Syrucek, Z. Zemanova, E. Krepela, J. Belacek, A. Sedo,
- 520 9_
- $a Glioblastomas are deadly neoplasms resistant to current treatment modalities. Fibroblast activation protein (FAP) is a protease which is not expressed in most of the normal adult tissues but is characteristically present in the stroma of extracranial malignancies. FAP is considered a potential therapeutic target and is associated with a worse patient outcome in some cancers. The FAP localization in the glioma microenvironment and its relation to patient survival are unknown. By analyzing 56 gliomas and 15 non-tumorous brain samples, we demonstrate increased FAP expression in a subgroup of high-grade gliomas, in particular on the protein level. FAP expression was most elevated in the mesenchymal subtype of glioblastoma. It was neither associated with glioblastoma patient survival in our patient cohort nor in publicly available datasets. FAP was expressed in both transformed and stromal cells; the latter were frequently localized around dysplastic blood vessels and commonly expressed mesenchymal markers. In a mouse xenotransplantation model, FAP was expressed in glioma cells in a subgroup of tumors that typically did not express the astrocytic marker GFAP. Endogenous FAP was frequently upregulated and part of the FAP(+) host cells coexpressed the CXCR4 chemokine receptor. In summary, FAP is expressed by several constituents of the glioblastoma microenvironment, including stromal non-malignant mesenchymal cells recruited to and/or activated in response to glioma growth. The limited expression of FAP in healthy tissues together with its presence in both transformed and stromal cells suggests that FAP may be a candidate target for specific delivery of therapeutic agents in glioblastoma.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a apoptóza $7 D017209
- 650 _2
- $a nádorové biomarkery $x metabolismus $7 D014408
- 650 _2
- $a western blotting $7 D015153
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a transformované buněčné linie $x metabolismus $x patologie $7 D002461
- 650 _2
- $a proliferace buněk $7 D049109
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fibroblasty $x metabolismus $x patologie $7 D005347
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a želatinasy $x genetika $x metabolismus $7 D018093
- 650 _2
- $a glioblastom $x genetika $x metabolismus $x patologie $7 D005909
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunoenzymatické techniky $7 D007124
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a membránové proteiny $x genetika $x metabolismus $7 D008565
- 650 _2
- $a mezoderm $x metabolismus $x patologie $7 D008648
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední NOD $7 D016688
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a messenger RNA $x genetika $7 D012333
- 650 _2
- $a kvantitativní polymerázová řetězová reakce $7 D060888
- 650 _2
- $a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
- 650 _2
- $a serinové endopeptidasy $x genetika $x metabolismus $7 D012697
- 650 _2
- $a buňky stromatu $x metabolismus $x patologie $7 D017154
- 650 _2
- $a míra přežití $7 D015996
- 650 _2
- $a nádorové buňky kultivované $7 D014407
- 650 _2
- $a xenogenní modely - testy protinádorové aktivity $7 D023041
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Balážiová, Eva $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic. $7 xx0126036
- 700 1_
- $a Matrasová, Ivana $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic. $7 xx0212899
- 700 1_
- $a Hilšer, Marek, $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic. $d 1976- $7 xx0208340
- 700 1_
- $a Tomáš, Robert $u Department of Neurosurgery, Na Homolce Hospital, Roentgenova 2, 150 30, Prague 5, Czech Republic. $7 xx0056248
- 700 1_
- $a Syrůček, Martin $u Department of Pathology, Na Homolce Hospital, Roentgenova 2, 150 30, Prague 5, Czech Republic. $7 xx0145890
- 700 1_
- $a Zemanová, Zuzana, $u Institute of Clinical Biochemistry and Laboratory Diagnostics of the First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, U Nemocnice 2, 128 01, Prague 2, Czech Republic. $d 1962- $7 nlk20050170627
- 700 1_
- $a Křepela, Evžen $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic. $7 xx0083612
- 700 1_
- $a Belacek, Jaromir $u Institute of Biophysics and Bioinformatics, First Faculty of Medicine, Charles University in Prague, Salmovská 1, 120 00, Prague 2, Czech Republic.
- 700 1_
- $a Šedo, Aleksi, $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic. aleksi@cesnet.cz. $d 1967- $7 jn20000605245
- 773 0_
- $w MED00008757 $t Tumour biology the journal of the International Society for Oncodevelopmental Biology and Medicine $x 1423-0380 $g Roč. 37, č. 10 (2016), s. 13961-13971
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27492457 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20191015080409 $b ABA008
- 999 __
- $a ok $b bmc $g 1200065 $s 974378
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 37 $c 10 $d 13961-13971 $e 20160804 $i 1423-0380 $m Tumor biology $n Tumor Biol $x MED00008757
- GRA __
- $a NT12237 $p MZ0
- LZP __
- $a Pubmed-20170413